Revelation Biosciences, Inc.

NASDAQ: REVB · Healthcare · Biotechnology

PublicHQ San Diego, CA · San DiegoCIK 0001810560Reports USD

#1 of 1,422 Healthcare companies by revenue

EA Score

——

FH 44DQ —GM —SS 30

v0.1 · 35/100 weight · pillars only

↑ filing timeliness, balance-sheet leverage · ↓ Piotroski F, workforce scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

-100.0%

Net income (FY)

-$8.9M

Employees

as of 2026-08-24

Market cap

$4.3M

as of 2026-08-24

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$8.9M-$8.9M2025

Operating income-$9.1M-$9.1M2025

Total assets$11.6M$11.6M2025

Liabilities$2.7M$2.7M2025

Equity$8.9M$8.9M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Revelation Biosciences, Inc.’s financial profile?

Revelation Biosciences, Inc. earned -$8.9M in FY2025 net income.

Peers · Healthcare

Qscreen Ai Inc.——Xcelerate Inc.——LianBio——KMA Holding, Inc.——Cann American Corp.——CTT Pharmaceutical Holdings, Inc.——

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Realty Income Corporation$5.7B60C Sempra$12.4B64C DexCom, Inc.$4.7B87A ResMed Inc.$5.1B88A Illumina, Inc.$4.3B84B+

Key facts

CEOJames Rolke

SectorHealthcare

IndustryBiotechnology

HeadquartersSan Diego, CA

ExchangeNASDAQ: REVB

Employees8

IPO date2020-11-17

Latest filings

8-K2026-08-19 8-K2026-08-06 10-Q2026-08-06 8-K2026-07-13 8-K2026-06-24 8-K2026-06-01 DEF 14A2026-05-11 8-K2026-05-07

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.